{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:29:38Z","timestamp":1788805778785,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04069-2","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:05:29Z","timestamp":1743703529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The comparative study of letibotulinum toxin A and onabotulinum toxin A in treatment of primary axillary hyperhidrosis"],"prefix":"10.1007","volume":"317","author":[{"given":"Sunatra","family":"Nitayavardhana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romun","family":"Leaovitavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"8","key":"4069_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/DSS.0000000000000429","volume":"41","author":"JS An","year":"2015","unstructured":"An JS, Won H, Si Han C, Park J, H. S., Seo KK (2015) Comparison of OnabotulinumtoxinA and RimabotulinumtoxinB for the treatment of axillary hyperhidrosis. Dermatol Surg 41(8):960\u2013967. https:\/\/doi.org\/10.1097\/DSS.0000000000000429","journal-title":"Dermatol Surg"},{"key":"4069_CR2","doi-asserted-by":"publisher","unstructured":"Chang HJ, Hong BY, Lee SJ, Lee S, Park JH, Kwon JY (2017) Efficacy and safety of letibotulinum toxin A for the treatment of dynamic equinus foot deformity in children with cerebral palsy: A randomized controlled trial. Toxins (Basel) 9(8). https:\/\/doi.org\/10.3390\/toxins9080252","DOI":"10.3390\/toxins9080252"},{"key":"4069_CR3","doi-asserted-by":"publisher","unstructured":"Choudhury S, Baker MR, Chatterjee S, Kumar H (2021) Botulinum toxin: an update on Pharmacology and newer products in development. Toxins (Basel) 13(1). https:\/\/doi.org\/10.3390\/toxins13010058","DOI":"10.3390\/toxins13010058"},{"key":"4069_CR4","unstructured":"Flanagan KH, King R, Glaser DA (2008) Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis. J Drugs Dermatol, 7(3), 221\u2013227. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18380203"},{"key":"4069_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/CCID.S160723","volume":"11","author":"J Frevert","year":"2018","unstructured":"Frevert J, Ahn KY, Park MY, Sunga O (2018) Comparison of botulinum neurotoxin type A formulations in Asia. Clin Cosmet Investig Dermatol 11:327\u2013331. https:\/\/doi.org\/10.2147\/CCID.S160723","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"11","key":"4069_CR6","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/1346-8138.12258","volume":"40","author":"T Fujimoto","year":"2013","unstructured":"Fujimoto T, Kawahara K, Yokozeki H (2013) Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol 40(11):886\u2013890. https:\/\/doi.org\/10.1111\/1346-8138.12258","journal-title":"J Dermatol"},{"issue":"5","key":"4069_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/pde.12620","volume":"32","author":"DA Glaser","year":"2015","unstructured":"Glaser DA, Pariser DM, Hebert AA, Landells I, Somogyi C, Weng E, Beddingfield F (2015) A prospective, nonrandomized, Open-Label study of the efficacy and safety of OnabotulinumtoxinA in adolescents with primary axillary hyperhidrosis. Pediatr Dermatol 32(5):609\u2013617. https:\/\/doi.org\/10.1111\/pde.12620","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"4069_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40257-019-00482-2","volume":"21","author":"E Hanna","year":"2020","unstructured":"Hanna E, Pon K (2020) Updates on botulinum neurotoxins in dermatology. Am J Clin Dermatol 21(2):157\u2013162. https:\/\/doi.org\/10.1007\/s40257-019-00482-2","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"4069_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10286-017-0456-0","volume":"27","author":"M Hashmonai","year":"2017","unstructured":"Hashmonai M, Cameron AEP, Connery CP, Perin N, Licht PB (2017) The etiology of primary hyperhidrosis: A systematic review. Clin Auton Res 27(6):379\u2013383. https:\/\/doi.org\/10.1007\/s10286-017-0456-0","journal-title":"Clin Auton Res"},{"issue":"4","key":"4069_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1590\/S1806-37562017000000379","volume":"44","author":"EN Hasimoto","year":"2018","unstructured":"Hasimoto EN, Cataneo DC, Reis TAD, Cataneo AJM (2018) Hyperhidrosis: prevalence and impact on quality of life. J Bras Pneumol 44(4):292\u2013298. https:\/\/doi.org\/10.1590\/S1806-37562017000000379","journal-title":"J Bras Pneumol"},{"issue":"10","key":"4069_CR11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1001\/archderm.141.10.1255","volume":"141","author":"M Heckmann","year":"2005","unstructured":"Heckmann M, Plewig G, Hyperhidrosis Study G (2005) Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol 141(10):1255\u20131259. https:\/\/doi.org\/10.1001\/archderm.141.10.1255","journal-title":"Arch Dermatol"},{"issue":"12","key":"4069_CR12","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1111\/jdv.12408","volume":"28","author":"BJ Kim","year":"2014","unstructured":"Kim BJ, Kwon HH, Park SY, Min SU, Yoon JY, Park YM, Suh DH (2014) Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC26, compared with onabotulinumtoxin A in the treatment of glabellar lines. J Eur Acad Dermatol Venereol 28(12):1761\u20131767. https:\/\/doi.org\/10.1111\/jdv.12408","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4069_CR13","doi-asserted-by":"publisher","unstructured":"Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY (2007) & North American Botox in Primary Axillary Hyperhidrosis Clinical Study, G. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol, 56(4), 604\u2013611. https:\/\/doi.org\/10.1016\/j.jaad.2007.01.009","DOI":"10.1016\/j.jaad.2007.01.009"},{"issue":"3","key":"4069_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2018.12.071","volume":"81","author":"S Nawrocki","year":"2019","unstructured":"Nawrocki S, Cha J (2019) The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: etiology and clinical work-up. J Am Acad Dermatol 81(3):657\u2013666. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.071","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4069_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jaad.2018.11.066","volume":"81","author":"S Nawrocki","year":"2019","unstructured":"Nawrocki S, Cha J (2019) The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: therapeutic options. J Am Acad Dermatol 81(3):669\u2013680. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.066","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4069_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a National survey. J Am Acad Dermatol 51(2):241\u2013248. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.040","journal-title":"J Am Acad Dermatol"},{"key":"4069_CR17","doi-asserted-by":"publisher","unstructured":"Talarico-Filho S, Mendonca DONM, Sperandeo DEMF (2007) & C, D. E. S. P. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Dermatol Surg, 33(1 Spec No.), S44-50. https:\/\/doi.org\/10.1111\/j.1524-4725.2006.32331.x","DOI":"10.1111\/j.1524-4725.2006.32331.x"},{"issue":"7","key":"4069_CR18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/jdv.17217","volume":"35","author":"KH Yoo","year":"2021","unstructured":"Yoo KH, Park SJ, Han HS, Won CH, Lee YW, Kim BJ (2021) Randomized, double-blind, active-controlled, multicentre, phase III clinical trial with two stages to assess the safety and efficacy of letibotulinum toxin a vs. onabotulinum toxin a for subjects with moderate to severe Crow\u2019s feet. J Eur Acad Dermatol Venereol 35(7):1587\u20131594. https:\/\/doi.org\/10.1111\/jdv.17217","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04069-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:05:37Z","timestamp":1743703537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4069"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04069-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"661"}}